126 related articles for article (PubMed ID: 36630756)
1. Heterogenous response to aging of astrocytes in murine Substantia Nigra pars compacta and pars reticulata.
Bondi H; Chiazza F; Masante I; Bortolotto V; Canonico PL; Grilli M
Neurobiol Aging; 2023 Mar; 123():23-34. PubMed ID: 36630756
[TBL] [Abstract][Full Text] [Related]
2. Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson's disease.
Moore C; Xu M; Bohlen JK; Meshul CK
Eur J Neurosci; 2021 Apr; 53(7):2061-2077. PubMed ID: 32619030
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
4. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.
Zhang Y; Meng X; Jiao Z; Liu Y; Zhang X; Qu S
ACS Chem Neurosci; 2020 Feb; 11(3):406-417. PubMed ID: 31909584
[TBL] [Abstract][Full Text] [Related]
5. Acute sensitivity of astrocytes in the Substantia Nigra to oxygen and glucose deprivation (OGD) compared with hippocampal astrocytes in brain slices.
Karunasinghe RN; Dean JM; Lipski J
Neurosci Lett; 2018 Oct; 685():137-143. PubMed ID: 30153493
[TBL] [Abstract][Full Text] [Related]
6. Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF.
Patel D; Jana A; Roy A; Pahan K
J Neuroimmune Pharmacol; 2019 Sep; 14(3):503-518. PubMed ID: 31119595
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.
Smeyne RJ; Breckenridge CB; Beck M; Jiao Y; Butt MT; Wolf JC; Zadory D; Minnema DJ; Sturgess NC; Travis KZ; Cook AR; Smith LL; Botham PA
PLoS One; 2016; 11(10):e0164094. PubMed ID: 27788145
[TBL] [Abstract][Full Text] [Related]
9. Distribution, connection and function of ALDH1A1
Liu H; Gong Z; Li Z; Ye T; Cao A; He S; Lin S; Duan J; Lin X
Neurosci Lett; 2024 Jan; 818():137555. PubMed ID: 37972684
[TBL] [Abstract][Full Text] [Related]
10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
11. Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta.
Jyothi HJ; Vidyadhara DJ; Mahadevan A; Philip M; Parmar SK; Manohari SG; Shankar SK; Raju TR; Alladi PA
Neurobiol Aging; 2015 Dec; 36(12):3321-3333. PubMed ID: 26433682
[TBL] [Abstract][Full Text] [Related]
12. Age-related differences in NMDA/metabotropic glutamate receptor binding in rat substantia nigra.
Hedberg TG; Velísková J; Sperber EF; Nunes ML; Moshé SL
Int J Dev Neurosci; 2003 Apr; 21(2):95-103. PubMed ID: 12615085
[TBL] [Abstract][Full Text] [Related]
13. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson's disease mouse model.
Zhou Y; Zhao WJ; Quan W; Qiao CM; Cui C; Hong H; Shi Y; Niu GY; Zhao LP; Shen YQ
Brain Res Bull; 2021 Nov; 176():174-183. PubMed ID: 34478811
[TBL] [Abstract][Full Text] [Related]
15. Age-mediated transcriptomic changes in adult mouse substantia nigra.
Gao L; Hidalgo-Figueroa M; Escudero LM; Díaz-Martín J; López-Barneo J; Pascual A
PLoS One; 2013; 8(4):e62456. PubMed ID: 23638090
[TBL] [Abstract][Full Text] [Related]
16. Glutamate transporter 1-expressing glia in the rat substantia nigra-Morphometric analysis and relationships to synapses.
Kessler JP; Salin P; Kerkerian-Le Goff L
Glia; 2020 Oct; 68(10):2028-2039. PubMed ID: 32170887
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper.
Almada RC; Roncon CM; Elias-Filho DH; Coimbra NC
Neuroscience; 2015 Sep; 303():503-14. PubMed ID: 26141842
[TBL] [Abstract][Full Text] [Related]
18. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
Burke MV; Nocjar C; Sonneborn AJ; McCreary AC; Pehek EA
J Neurochem; 2014 Nov; 131(4):432-43. PubMed ID: 25073477
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase.
Watts PM; Riedl AG; Douek DC; Edwards RJ; Boobis AR; Jenner P; Marsden CD
Neuroscience; 1998 Sep; 86(2):511-9. PubMed ID: 9881865
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
